These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2430058)

  • 1. Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system.
    Memo M; Castelletti L; Missale C; Valerio A; Carruba M; Spano PF
    J Neurochem; 1986 Dec; 47(6):1689-95. PubMed ID: 2430058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary.
    Memo M; Castelletti L; Valerio A; Missale C; Spano PF
    J Neurochem; 1986 Dec; 47(6):1682-8. PubMed ID: 2430057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
    Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
    Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Valerio A; Alberici A; Tinti C; Spano P; Memo M
    J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
    Lafond J; Ducharme JR; Collu R
    Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dynamics of arachidonic acid liberation and prolactin release: a comparison of thyrotropin-releasing hormone, angiotensin II, and neurotensin stimulation in perifused rat anterior pituitary cells.
    Ross PC; Judd AM; MacLeod RM
    Endocrinology; 1988 Nov; 123(5):2445-53. PubMed ID: 3139397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors.
    Wang X; Sato N; Greer MA; Falardeau P
    Mol Cell Endocrinol; 1995 Aug; 112(2):153-7. PubMed ID: 7489818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dopamine and neurotensin on calcium fluxes and prolactin release in normal rat pituitary cells.
    Login IS; Kuan SI; Judd AM; MacLeod RM
    Endocrinology; 1990 Oct; 127(4):1948-55. PubMed ID: 1698150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses.
    Mau SE
    J Mol Endocrinol; 1997 Jun; 18(3):181-91. PubMed ID: 9195472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP; Stringer LC; Freeman ME
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of corticosteroids on prolactin release from anterior pituitary cell aggregates cultured in serum-free medium. Differential effects on dopamine-induced inhibition, post-dopamine rebound and stimulation by TRH, vasoactive intestinal peptide (VIP), angiotensin II and isoproterenol.
    Denef C; Schramme C; Baes M
    J Steroid Biochem; 1984 Jan; 20(1):197-202. PubMed ID: 6423898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
    Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
    Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible involvement of both calcium and cyclic AMP in the dopaminergic inhibition of prolactin secretion.
    Merritt JE; Brown BL
    Life Sci; 1984 Aug; 35(7):707-11. PubMed ID: 6206370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
    Enjalbert A; Musset F; Chénard C; Priam M; Kordon C; Heisler S
    Endocrinology; 1988 Jul; 123(1):406-12. PubMed ID: 2454806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic reduction of intracellular calcium: the role of calcium influx.
    Login IS; Judd AM; MacLeod RM
    Biochem Biophys Res Commun; 1988 Mar; 151(2):913-8. PubMed ID: 3348820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
    Delbeke D; Dannies PS
    Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.